# Lansionbio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lansionbio

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Website: www.lansionbio.com
- Total disclosed funding: $19M
- Latest round: Series D (Feb 18, 2022)
- Investors on record: 10

## About

Based in Nanjing, China and established in 2016, Lansion Biotechnology Co., Ltd. doing business named as Lansionbio, operates as a biotechnology company that engages in the R&D, production, sales, and services of in vitro diagnostic (IVD) reagents and devices. It has 150 R&D researchers and established a R&D centre covering 20,000 square meters, including a 4,000 square meters aseptic cleanroom. Besides, Lansionbio has more than 200 patents. Moreover, it owns 4 subsidiaries in Guangxi, Shanxi, Chengdu, and Nanjing. 

Lansionbio provides IVD reagents and devices. The IVD reagents include COVID-19 antigen test kits, and point of care testing (POCT) kits. And the IVD devices include chemiluminescence immunoassay analyzers, and handheld coagulation analyzers. The POCT kits tested for inflammation, diabetes, tumors, brain injury, bone metabolism, and other diseases.

## Funding rounds

- Series D, Feb 18, 2022 — China International Capital Corporation, Dynamic Capital
- Series D, Dec 30, 2020 — China Renaissance, MPC
- Series C, Sep 30, 2019, $14M — Coastal Capital, MPC
- Series B, Sep 28, 2018 — K2VC
- Series A, Jan 8, 2018, $5.4M — CID Group, Green Pine Capital Partners, Liyuan Venture Capital, Watson Capital

## Investors

- CID Group (https://capitalatlas.ai/funds/cid-group) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A
- Liyuan Venture Capital (https://capitalatlas.ai/funds/liyuan-venture-capital) — Series A
- Watson Capital (https://capitalatlas.ai/funds/watson-capital) — Series A
- K2VC (https://capitalatlas.ai/funds/k2vc) — Series B
- Coastal Capital (https://capitalatlas.ai/funds/coastal-capital) — Series C
- MPC — Series C, Series D
- China Renaissance (https://capitalatlas.ai/funds/china-renaissance) — Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D
- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Series D